|
1235
|
Abnormal cannabidiol
|
Cannabinoid agonist |
€135.00
|
|
2898
|
AC 264613
|
Potent, selective, and metabolically stable PAR2 agonist |
€95.00
|
|
2541
|
APD 597
|
Orally bioavailable selective GPR119 agonist |
€125.00
|
|
2380
|
APD 668
|
Potent and selective, orally active GPR119 agonist |
€125.00
|
|
1572
|
AR 231453
|
Cannabinoid GPR119 agonist |
€80.00
|
|
3430
|
AS1269574
|
Selective and orally available GPR119 agonist |
€90.00
|
|
1234
|
Cannabidiol
|
GPR55 antagonist |
€105.00
|
|
2030
|
E 5555 hydrobromide
|
Potent and orally active PAR1 antagonist |
€115.00
|
|
1622
|
GB83
|
PAR2 antagonist |
€110.00
|
|
3043
|
I-191
|
Potent PAR2 antagonist |
€175.00
|
|
2092
|
MBX 2982
|
Potent and selective GPR119 agonist |
€125.00
|
|
1928
|
ML 161
|
Allosteric inhibitor of PAR1 |
€90.00
|
|
3028
|
ML184
|
Potent and selective GPR55 agonist |
€120.00
|
|
2899
|
ML354
|
Potent and selective PAR4 antagonist |
€120.00
|
|
3230
|
ML401
|
Potent functional antagonist of EBI-2 |
€90.00
|
|
3231
|
NIBR189
|
Potent and selective EBI-2 antagonist |
€95.00
|
|
1211
|
Palmitoylethanolamide
|
Endocannabinoid; GPR55 agonist |
€75.00
|
|
2055
|
Q94 hydrochloride
|
Negative allosteric modulator of PAR1 (Gαq linkage) |
€80.00
|
|
1755
|
SCH 530348
|
PAR1 antagonist |
€150.00
|
|
1275
|
SCH 79797 dihydrochloride
|
PAR1 antagonist |
€130.00
|